stoxline Quote Chart Rank Option Currency Glossary
  
Waters Corporation (WAT)
311.95  12.72 (4.25%)    04-23 11:10
Open: 309.99
High: 313.47
Volume: 188,561
  
Pre. Close: 299.23
Low: 306.09
Market Cap: 18,502(M)
Technical analysis
2024-04-23 10:51:57 AM
Short term     
Mid term     
Targets 6-month :  385.67 1-year :  415.45
Resists First :  330.19 Second :  355.7
Pivot price 322.12
Supports First :  288.94 Second :  240.39
MAs MA(5) :  301.1 MA(20) :  327.18
MA(100) :  323.73 MA(250) :  291.03
MACD MACD :  -10.4 Signal :  -6.9
%K %D K(14,3) :  23.3 D(3) :  14.9
RSI RSI(14): 40.5
52-week High :  363.79 Low :  231.89
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ WAT ] has closed above bottom band by 35.0%. Bollinger Bands are 96.6% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 4 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 301.32 - 302.76 302.76 - 304.07
Low: 291.12 - 292.82 292.82 - 294.36
Close: 296.45 - 299.22 299.22 - 301.74
Company Description

Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by life science, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.

Headline News

Mon, 22 Apr 2024
Waters Accelerates the Development of Gene-based Therapeutics with New GTxResolve Premier SEC Columns - PR Newswire

Fri, 19 Apr 2024
Waters Corp. stock outperforms competitors on strong trading day - MarketWatch

Thu, 18 Apr 2024
Waters Corp. stock underperforms Thursday when compared to competitors - MarketWatch

Thu, 18 Apr 2024
Is Waters Corporation's (NYSE:WAT) ROE Of 56% Impressive? - Yahoo Finance

Sun, 07 Apr 2024
Is It Too Late To Consider Buying Waters Corporation (NYSE:WAT)? - Simply Wall St

Mon, 11 Mar 2024
Waters Corporation: A Great (Share Price) Run (NYSE:WAT) - Seeking Alpha

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Medical - Diagnostics & Research
Shares Out 59 (M)
Shares Float 59 (M)
Held by Insiders 0 (%)
Held by Institutions 102 (%)
Shares Short 3,790 (K)
Shares Short P.Month 3,750 (K)
Stock Financials
EPS 10.84
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 19.44
Profit Margin 21.7 %
Operating Margin 36.9 %
Return on Assets (ttm) 13.5 %
Return on Equity (ttm) 77.6 %
Qtrly Rev. Growth -4.5 %
Gross Profit (p.s.) 0
Sales Per Share 49.9
EBITDA (p.s.) 17.19
Qtrly Earnings Growth -4.2 %
Operating Cash Flow 603 (M)
Levered Free Cash Flow 444 (M)
Stock Valuations
PE Ratio 28.76
PEG Ratio 4.9
Price to Book value 16.03
Price to Sales 6.24
Price to Cash Flow 30.67
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android